Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss

While more large employers are covering GLP-1 drugs for weight loss, KFF’s conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in some cases, employers are adding or strengthening coverage requirements.

Leave a Reply

Your email address will not be published. Required fields are marked *